Molecular Remission Confirmed by Monitoring a PTPN11 Mutation in Myeloid Leukemia of Down Syndrome Treated With
Taro Yoshida1, Hideki Muramatsu2, Shuta Ishikawa1
1Department of Pediatrics, School of Medicine, Iwate Medical University, Yahaba, Japan.
Pediatric Blood & Cancer
|December 27, 2025
Abstract
No abstract available in PubMed .
More Related Videos
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
10.1K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.3K
